Regenerative Medical Technology (RMTG) Current Leases (2022 - 2025)
Historic Current Leases for Regenerative Medical Technology (RMTG) over the last 4 years, with Q3 2025 value amounting to $186516.0.
- Regenerative Medical Technology's Current Leases rose 14511.91% to $186516.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $186516.0, marking a year-over-year increase of 14511.91%. This contributed to the annual value of $63540.0 for FY2024, which is 224119.38% up from last year.
- Latest data reveals that Regenerative Medical Technology reported Current Leases of $186516.0 as of Q3 2025, which was up 14511.91% from $64176.0 recorded in Q2 2025.
- In the past 5 years, Regenerative Medical Technology's Current Leases ranged from a high of $186516.0 in Q3 2025 and a low of $2714.0 during Q4 2023
- For the 4-year period, Regenerative Medical Technology's Current Leases averaged around $53029.0, with its median value being $32568.0 (2022).
- Per our database at Business Quant, Regenerative Medical Technology's Current Leases plummeted by 9166.67% in 2023 and then soared by 224119.38% in 2024.
- Over the past 4 years, Regenerative Medical Technology's Current Leases (Quarter) stood at $32568.0 in 2022, then tumbled by 91.67% to $2714.0 in 2023, then soared by 2241.19% to $63540.0 in 2024, then soared by 193.54% to $186516.0 in 2025.
- Its Current Leases stands at $186516.0 for Q3 2025, versus $64176.0 for Q2 2025 and $64176.0 for Q1 2025.